deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT02121977

Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse (Embrace)

A Prospective, Safety and Efficacy Cohort Study of Elevate® Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse Repair

Sponsor: ASTORA Women's Health

Updated 6 times since 2017 Last updated: Sep 6, 2016 Started: Apr 30, 2014 Primary completion: Apr 30, 2019 Completion: Apr 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Astora business is closing

Other terminated trials from ASTORA Women's Health

More terminations from ASTORA Women's Health

Listed as NCT02121977, this PHASE4 trial focuses on Pelvic Organ Prolapse and remains terminated or withdrawn. Sponsored by ASTORA Women's Health, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ASTORA Women's Health
Data source: ASTORA Women's Health

For direct contact, visit the study record on ClinicalTrials.gov .